El, Jurdi, N; Holtzman, NG; Hishmeh, R; Mina, A; Schulz, E; Stokes, A; Li, G; Schmidt, KT; Figg, WD; Micheletti, N; Mays, JW; Cowen, EW; Pavletic, SZ; Pusic, I.
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned.
Br J Haematol. 2025;
Doi: 10.1111/bjh.20069
Web of Science
PubMed
FullText
FullText_MUG